Sitahenz M 500 Tablet

Original price was: ₹140.00.Current price is: ₹126.00.

Sitahenz M 500 Tablet is a prescription medication commonly used to manage and control blood sugar levels in individuals with type 2 diabetes. The tablet contains a combination of Sitagliptin and Metformin, two active ingredients that work synergistically to improve glucose control by enhancing insulin sensitivity and reducing glucose production in the liver. Sitahenz M 500 is typically prescribed as part of a comprehensive treatment plan that includes diet, exercise, and lifestyle modifications to help patients achieve better glycemic control and reduce the risk of diabetes-related complications. Always use this medication under the guidance and supervision of a healthcare professional.


**Product: Sitahenz M 500 Tablet**

– **Metformin:** 500 mg
– **Sitagliptin Phosphate:** Variable strengths, typically 50 mg or 100 mg per tablet

Sitahenz M 500 Tablet is a combination medication used primarily for the management of Type 2 diabetes mellitus. This oral hypoglycemic agent integrates two active pharmaceutical ingredients, Metformin and Sitagliptin Phosphate, resulting in a synergistic effect for better blood glucose control.

– **Class:** Biguanide
– **Mechanism of Action:** Metformin works by decreasing hepatic glucose production (gluconeogenesis) and improving insulin sensitivity in muscles and liver, thereby facilitating the uptake and utilization of glucose.
– **Benefits:** Effective in reducing basal and postprandial glucose levels, promoting weight neutrality or slight weight loss, and improving lipid profiles in patients with Type 2 diabetes.

**Sitagliptin Phosphate:**
– **Class:** Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
– **Mechanism of Action:** Sitagliptin enhances the body’s natural ability to lower elevated blood sugar levels. It works by increasing the levels of incretins (hormones released after eating), which stimulate insulin release from the pancreas and decrease the amount of glucose produced by the liver.
– **Benefits:** Improves glycemic control without significant weight gain, has a low risk of hypoglycemia when used alone, and can be used safely in conjunction with other antidiabetic medications.

Sitahenz M 500 Tablet is indicated for:
– The control of blood glucose levels in adults with Type 2 diabetes mellitus.
– Use as an adjunct to diet and exercise to improve glycemic control.
– It may be used as a first-line therapy or in cases where monotherapy with Metformin or Sitagliptin alone does not achieve adequate glycemic control.

– **Effective Glycemic Control:** The combination of Metformin and Sitagliptin targets multiple pathways involved in glucose regulation, providing a comprehensive approach to managing Type 2 diabetes.
– **Convenience:** Instead of taking multiple medications, patients can use a single tablet to achieve the desired therapeutic outcomes.
– **Reduced Risk of Hypoglycemia:** Sitagliptin, when combined with Metformin, is associated with a lower risk of hypoglycemia compared to other insulinotropic medications.
– **Weight Management:** Sitahenz M 500 has neutral or positive effects on body weight, making it a favorable choice for obese or overweight patients with Type 2 diabetes.

**Administration & Dosage:**
– The dosage of Sitahenz M 500 should be individualized based on the patient’s current treatment regimen, effectiveness, and tolerance, but commonly begins with one tablet once or twice daily with meals.
– Regular monitoring of blood glucose levels is recommended to maintain optimal control.

– Sitahenz M 500 should not be used in patients with Type 1 diabetes or for the treatment of diabetic ketoacidosis.
– It is contraindicated in individuals with severe renal impairment or known hypersensitivity to any component of the tablet.
– Regular follow-up with a healthcare provider is essential to monitor the efficacy and safety of the therapy.

Always consult with a healthcare professional before starting any new medication.

Additional information

Weight 35.0 g
Marketed by


Dosage form




Therapeutic use